about
The discovery of carboline analogs as potent MAPKAP-K2 inhibitorsHit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding modePim kinase inhibitors: a survey of the patent literatureDiscovery of 2-phenylamino-imidazo[4,5-h]isoquinolin-9-ones: a new class of inhibitors of lck kinase.EFFECT OF TOTAL DAILY DOSE ON EFFICACY, DOSING, AND SAFETY OF 2 DOSE TITRATION REGIMENS OF HUMAN REGULAR U500 INSULIN IN SEVERELY INSULIN-RESISTANT PATIENTS WITH TYPE 2 DIABETES.Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK).Tandem alkylation/ester hydrolysis using polymer-supported hydroxide for catch and release isolation of a series of benzoimidazolonecarboxylic acids.Understanding concentrated insulins: a systematic review of randomized controlled trials.Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen.Lilly Insulin Glargine Versus Lantus in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)A practical approach to the synthesis of 2,4-disubstituted oxazoles from amino acidsCombined Addition of Alkenyl and Allenic Anions to Squarate Esters. Direct Competition between Six-Ring and Eight-Ring Electrocyclization of 1,2,4,6,8-Cumulenic PentaenesHigh-throughput ester hydrolysis with catch-and-release isolation of carboxylic acidsEvolution of the thienopyridine class of inhibitors of IkappaB kinase-beta: part I: hit-to-lead strategiesThe discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part II
P50
Q27646039-11810749-BD49-4A3C-B855-7656A8AE0487Q27653999-23DFDFC5-AA94-4660-B272-6CE6166C9D0FQ28271318-05E32F67-F1E4-4DE9-98C2-162652E7F523Q39123389-46EA1C2E-FB1D-4D07-85E8-25EDE5B7E668Q40083907-F9B134EB-E089-4C93-B121-FB16056517F3Q44385152-34EC12F8-76FD-48F2-9EE7-7398D925D5B8Q46537261-845D2465-EB23-4BCE-B0D9-8A7F4D168095Q47322851-11671455-0DF6-4755-9642-150677AA795BQ48564940-24C21B2B-A7B1-48A2-906E-F73DFD65FCC1Q61807531-11BC45A0-1EBA-4593-B2E6-F22AE8578737Q74556026-5F84DD96-0851-4DE9-AEA4-975873534F37Q74835486-B772C6E5-7E4A-4D52-80C4-09BABE7EE32AQ80232559-D7BB6201-26A0-41BB-8B20-736D95B8690CQ83314133-2DCBC764-55AD-4520-BE15-62A3633A9398Q84488274-E1664990-1549-4DB3-86B0-6650B8838E23
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tina M Morwick
@ast
Tina M Morwick
@en
Tina M Morwick
@es
Tina M Morwick
@nl
type
label
Tina M Morwick
@ast
Tina M Morwick
@en
Tina M Morwick
@es
Tina M Morwick
@nl
prefLabel
Tina M Morwick
@ast
Tina M Morwick
@en
Tina M Morwick
@es
Tina M Morwick
@nl
P106
P31
P496
0000-0002-2194-951X